ClinicalTrialsFinder

Oligometastatic Squamous Cell Carcinoma of the Head and Neck Clinical Trials in Brussels

1 recruitingBrussels, Belgium

Showing 1–1 of 1 trials

Recruiting
Phase 3

Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

Oligometastatic Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC200 enrolled26 locationsNCT05815927